These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 1437336)

  • 1. On exogenous surfactant therapy.
    Merritt TA; Halliday HL
    Pediatr Pulmonol; 1992 Sep; 14(1):1-3. PubMed ID: 1437336
    [No Abstract]   [Full Text] [Related]  

  • 2. Surfactant phospholipids and surface activity among preterm infants with respiratory distress syndrome who develop bronchopulmonary dysplasia.
    Kazzi SN; Schürch S; McLaughlin KL; Romero R; Janisse J
    Acta Paediatr; 2000 Oct; 89(10):1218-25. PubMed ID: 11083379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimally Invasive Surfactant Therapy vs Sham Treatment and Death or Bronchopulmonary Dysplasia in Preterm Infants With Respiratory Distress Syndrome.
    Razak A
    JAMA; 2022 Apr; 327(16):1613. PubMed ID: 35471524
    [No Abstract]   [Full Text] [Related]  

  • 4. Minimally Invasive Surfactant Therapy vs Sham Treatment and Death or Bronchopulmonary Dysplasia in Preterm Infants With Respiratory Distress Syndrome.
    Zhou P; Han T
    JAMA; 2022 Apr; 327(16):1613-1614. PubMed ID: 35471523
    [No Abstract]   [Full Text] [Related]  

  • 5. Minimally Invasive Surfactant Therapy vs Sham Treatment and Death or Bronchopulmonary Dysplasia in Preterm Infants With Respiratory Distress Syndrome-Reply.
    Dargaville PA; Carlin JB; Davis PG;
    JAMA; 2022 Apr; 327(16):1614-1615. PubMed ID: 35471518
    [No Abstract]   [Full Text] [Related]  

  • 6. Economic impact of porcine surfactant replacement (Curosurf) for severe neonatal respiratory distress syndrome.
    Tubman TR; Halliday HL; Normand C
    J Perinat Med; 1991; 19 Suppl 1():403-7. PubMed ID: 1779394
    [No Abstract]   [Full Text] [Related]  

  • 7. Neonatal surfactant therapy--where do we go from here?
    Martin RJ
    J Pediatr; 1991 Apr; 118(4 Pt 1):555-6. PubMed ID: 2007929
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effects of surfactant administration in neonates with respiratory distress syndrome. II. Radiographic changes].
    Gadzinowski J; Halliday H; Szymankiewicz M; Rzymska I; Solawa M
    Ginekol Pol; 1992 Aug; 63(8):373-6. PubMed ID: 1304522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of surfactant-TA, calfactant and poractant alfa for preterm infants with respiratory distress syndrome: a retrospective study.
    Jeon GW; Oh M; Sin JB
    Yonsei Med J; 2015 Mar; 56(2):433-9. PubMed ID: 25683992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Natural or synthetic surfactant in the treatment of neonatal respiratory distress syndrome].
    Robertson B; Sangstad OD
    Tidsskr Nor Laegeforen; 1994 Feb; 114(5):590-1. PubMed ID: 8209345
    [No Abstract]   [Full Text] [Related]  

  • 11. Single dose surfactant rescue therapy in neonatal respiratory distress syndrome.
    Sanghvi KP; Merchant RH
    Indian Pediatr; 1998 Jun; 35(6):533-6. PubMed ID: 10216648
    [No Abstract]   [Full Text] [Related]  

  • 12. Effectiveness of curosurf for severe respiratory distress syndrome: a case-control study.
    Valls-i-Soler A; Lizarraga M; López de Heredia J; Roman L; Hernáez E; Gastiasoro E
    Biol Neonate; 1992; 61 Suppl 1():21-5. PubMed ID: 1391261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of artificial surfactant (ALEC) in the prophylaxis of neonatal respiratory distress syndrome.
    Morley CJ
    Eur Respir J Suppl; 1989 Mar; 3():81s-86s. PubMed ID: 2663001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 10 Years of research on porcine derived lung surfactant. Proceedings and abstracts of the 10th International Workshop on Surfactant Replacement. Versailles, France, May 14-16, 1995.
    Biol Neonate; 1995; 67 Suppl 1():1-92. PubMed ID: 7647154
    [No Abstract]   [Full Text] [Related]  

  • 15. [Secondary surfactant deficiencies].
    Escande B; Kuhn P; Rivera S; Messer J
    Arch Pediatr; 2004 Nov; 11(11):1351-9. PubMed ID: 15519836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of severe respiratory distress syndrome with surfactant].
    Jacobsen T; Verder H; Skov L; Greisen GO; Friis-Hansen B
    Ugeskr Laeger; 1992 Jun; 154(23):1642-5. PubMed ID: 1631999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late Surfactant Administration in Very Preterm Neonates With Prolonged Respiratory Distress and Pulmonary Outcome at 1 Year of Age: A Randomized Clinical Trial.
    Hascoët JM; Picaud JC; Ligi I; Blanc T; Moreau F; Pinturier MF; Zupan V; Guilhoto I; Hamon IR; Alexandre C; Bouissou A; Storme L; Patkai J; Pomedio M; Rouabah M; Coletto L; Vieux R
    JAMA Pediatr; 2016 Apr; 170(4):365-72. PubMed ID: 26928567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Porcine-derived lung surfactant. A review of the therapeutic efficacy and clinical tolerability of a natural surfactant preparation (Curosurf) in neonatal respiratory distress syndrome.
    Wiseman LR; Bryson HM
    Drugs; 1994 Sep; 48(3):386-403. PubMed ID: 7527760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Value of surfactant in the treatment of acute respiratory distress syndrome in a child].
    Fraisse A; Paut O; Silicani MA; Viard L; Camboulives J
    Arch Pediatr; 1996 Sep; 3(9):891-5. PubMed ID: 8949353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Have we been down this road before?
    Lutchman D
    J Perinatol; 2010 Oct; 30(10):698-9; author reply 698. PubMed ID: 20877366
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.